Clinical trials
Recruiting Cognitive Dysfunction trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 1 |
| National Cancer Centre, Singapore | 1 |
| National Heart Centre Singapore | 1 |
| National Neuroscience Institute | 1 |
| National University Hospital, Singapore | 1 |
| National University of Singapore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 6 |
| Dementia | 2 |
| Alzheimer Disease | 1 |
| Cardiovascular Diseases | 1 |
| Cerebrovascular Disorders | 1 |
| Frailty | 1 |
| Neurodegenerative Diseases | 1 |
| Sleep Apnea, Obstructive | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.